Track the Nuo Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Nuo Therapeutics, Inc. has logged 32 reports. Market capitalisation: €53.3m. The latest transaction was reported on 31 August 2026 (Acquisition). Among the most active insiders: JORDEN DAVID EMERSON. Every trade is free.
32
Insider Decl.
n/a
Thresholds
€1m
8 ops.
Buy Volume
€303,263
2 ops.
Sell Volume
29Σ signal
Buys €1m€303,263 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,912 of 29,064 companies
34.2
score / 100
Value
26
Quality
42
FCF yld-2.1%
Earn yld-4.7%
EV/EBITDA·
ROE·
Gross mgn67%
Net mgn-76%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
62,500 shares@ US$2.0010.3% of flowCommon StockSEC:0001437749-23-022109:0
Canonical exit: 30 Oct 2023 (T+90)
25 of 32 declarations
Acerca de Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. es una empresa de biotecnología centrada en el desarrollo de tratamientos para enfermedades crónicas. Su objetivo es proporcionar soluciones innovadoras para mejorar la salud del paciente.